Back to Search
Start Over
A case of pediatric psoriasis successfully and rapidly treated with ixekizumab.
- Source :
-
Dermatologic Therapy . Nov2021, Vol. 34 Issue 6, p1-2. 2p. - Publication Year :
- 2021
-
Abstract
- Particularly, conventional systemic treatments are approved only after 18 years of age while phototherapy is time-consuming showing logistic concerns.3 Biologics represent the only officially approved systemic drugs for moderate-to-severe pediatric psoriasis. We observed a complete skin clearance after only 4 weeks of treatment together with a huge improvement in quality of life and skin symptoms (PASI; 0, BSA 0%, Figure 1C,D); these results were maintained up to the last follow up at 24 weeks of treatment. His failed treatment history was wide: topical agents (0.05% clobetasol propionate), 16 weeks of oral cyclosporine (2.5 mg/kg/day) at the age of 9 years and 24 weeks of nb-UVB therapy when he was 10 years. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 13960296
- Volume :
- 34
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Dermatologic Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 154045572
- Full Text :
- https://doi.org/10.1111/dth.15108